Literature DB >> 26305671

Classical complement pathway activation in immune thrombocytopenia purpura: inhibition by a novel C1s inhibitor.

Ellinor I B Peerschke1,2, Sandip Panicker3, James Bussel4.   

Abstract

Entities:  

Keywords:  C1s inhibition; complement; immune thrombocytopenia purpura

Mesh：

Substances：

Year:  2015        PMID： 26305671      PMCID： PMC4973859          DOI： 10.1111/bjh.13648

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  10 in total

Review 1.  Role of splenectomy in immune (idiopathic) thrombocytopenic purpura.

Authors:  W R Bell
Journal:  Blood Rev       Date:  2002-03       Impact factor: 8.250

2.  Studies of the biologic effects of selective C4 deficiency.

Authors:  M M Frank; J E May; M A Kane
Journal:  Birth Defects Orig Artic Ser       Date:  1975

Review 3.  Antiplatelet antibodies in chronic immune thrombocytopenia and their role in platelet destruction and defective platelet production.

Authors:  Robert McMillan
Journal:  Hematol Oncol Clin North Am       Date:  2009-12       Impact factor: 3.722

Review 4.  Complement activation on platelets: implications for vascular inflammation and thrombosis.

Authors:  Ellinor I Peerschke; Wei Yin; Berhane Ghebrehiwet
Journal:  Mol Immunol       Date:  2010-06-01       Impact factor: 4.407

5.  Autoantibody-mediated complement activation on platelets is a common finding in patients with immune thrombocytopenic purpura (ITP).

Authors:  Abderrahim Najaoui; Tamam Bakchoul; Johanna Stoy; Gregor Bein; Mathias J Rummel; Sentot Santoso; Ulrich J Sachs
Journal:  Eur J Haematol       Date:  2011-11-22       Impact factor: 2.997

Review 6.  Pathogenesis in immune thrombocytopenia: new insights.

Authors:  Jill Johnsen
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2012

7.  Fixation of C3 to platelets in vitro by antiplatelet antibody from patients with immune thrombocytopenic purpura.

Authors:  R McMillan; M Martin
Journal:  Br J Haematol       Date:  1981-02       Impact factor: 6.998

8.  Complement activation on platelets correlates with a decrease in circulating immature platelets in patients with immune thrombocytopenic purpura.

Authors:  Ellinor I B Peerschke; Biree Andemariam; Wei Yin; James B Bussel
Journal:  Br J Haematol       Date:  2009-11-19       Impact factor: 6.998

9.  Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein.

Authors:  R Malhotra; M R Wormald; P M Rudd; P B Fischer; R A Dwek; R B Sim
Journal:  Nat Med       Date:  1995-03       Impact factor: 53.440

10.  TNT003, an inhibitor of the serine protease C1s, prevents complement activation induced by cold agglutinins.

Authors:  Ju Shi; Eileen L Rose; Andrew Singh; Sami Hussain; Nancy E Stagliano; Graham C Parry; Sandip Panicker
Journal:  Blood       Date:  2014-04-02       Impact factor: 22.113
  10 in total
  10 in total

1.  C1s Inhibition by BIVV009 (Sutimlimab) Prevents Complement-Enhanced Activation of Autoimmune Human B Cells In Vitro.

Authors:  Pavel A Nikitin; Eileen L Rose; Tony S Byun; Graham C Parry; Sandip Panicker
Journal:  J Immunol       Date:  2019-01-11       Impact factor: 5.422

2.  Serum complement levels in immune thrombocytopenia: Characterization and relation to clinical features.

Authors:  Abraham Z Cheloff; David J Kuter; Hanny Al-Samkari
Journal:  Res Pract Thromb Haemost       Date:  2020-06-21

3.  Secondary Complement Deficiency Impairs Anti-Microbial Immunity to Klebsiella pneumoniae and Staphylococcus aureus During Severe Acute COVID-19.

Authors:  Youssif M Ali; Nicholas J Lynch; Priyanka Khatri; Ifeoluwa E Bamigbola; Andrew C Y Chan; Munehisa Yabuki; Gregory A Demopulos; Jonathan L Heeney; Sumita Pai; Helen Baxendale; Wilhelm J Schwaeble
Journal:  Front Immunol       Date:  2022-04-27       Impact factor: 8.786

4.  Complement activation in patients with immune thrombocytopenic purpura according to phases of disease course.

Authors:  R Castelli; G Lambertenghi Delilliers; A Gidaro; M Cicardi; L Bergamaschini
Journal:  Clin Exp Immunol       Date:  2020-07-06       Impact factor: 4.330

Review 5.  The Centenary of Immune Thrombocytopenia - Part 1: Revising Nomenclature and Pathogenesis.

Authors:  Rita Consolini; Annalisa Legitimo; Maria Costanza Caparello
Journal:  Front Pediatr       Date:  2016-10-19       Impact factor: 3.418

Review 6.  Novel Therapies to Address Unmet Needs in ITP.

Authors:  María Eva Mingot-Castellano; José María Bastida; Gonzalo Caballero-Navarro; Laura Entrena Ureña; Tomás José González-López; José Ramón González-Porras; Nora Butta; Mariana Canaro; Reyes Jiménez-Bárcenas; María Del Carmen Gómez Del Castillo Solano; Blanca Sánchez-González; Cristina Pascual-Izquierdo
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-23

Review 7.  Immune Thrombocytopenia: Recent Advances in Pathogenesis and Treatments.

Authors:  Sylvain Audia; Matthieu Mahévas; Martin Nivet; Sethi Ouandji; Marion Ciudad; Bernard Bonnotte
Journal:  Hemasphere       Date:  2021-06-01

Review 8.  A Review of Romiplostim Mechanism of Action and Clinical Applicability.

Authors:  James B Bussel; Gerald Soff; Adriana Balduzzi; Nichola Cooper; Tatiana Lawrence; John W Semple
Journal:  Drug Des Devel Ther       Date:  2021-05-26       Impact factor: 4.162

9.  Idiopathic Thrombocytopenic Purpura Misdiagnosed as Hereditary Angioedema.

Authors:  Michelle Fog Andersen; Anette Bygum
Journal:  Case Rep Dermatol Med       Date:  2015-12-24

Review 10.  Complement in Hemolysis- and Thrombosis- Related Diseases.

Authors:  Shanshan Luo; Desheng Hu; Moran Wang; Peter F Zipfel; Yu Hu
Journal:  Front Immunol       Date:  2020-07-10       Impact factor: 7.561
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.